Malaria remains one of the greatest global health threats. In 2022, there were an estimated 247 million infections and over ...

has said that more than one million children in Plateau received free seasonal malaria chemoprevention drug in 2024. Kolawole ...

Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to treat ...

A new, comprehensive map of all the genes essential for blood infections in Plasmodium knowlesi (P. knowlesi), a parasite ...

Resistance to antimalarial drugs is a growing concern with research indicating that resistance to first-line treatments has ...

has said that more than one million children in Plateau received free seasonal malaria chemoprevention drug in 2024. Kolawole made this known in Jos on Saturday during the 2025 Seasonal Malaria ...

That has presented a "clear and present danger" that strains of P falciparum and other malaria parasites may emerge that are resistant to all current drugs. "These results are definitely good news ...

The parasite that causes malaria requires precise control of gene expression to progress through the various stages of its ...

Almost all the drugs that are widely used today against Plasmodium spp., the causative agent of malaria, target the asexual blood stages of the parasite. Widespread drug resistance severely ...

Cambodian scientist Yeang Chheang has spent six decades fighting malaria—even in the Khmer Rouge labor camp where his wife ...